What Is the Future of Factor XI Inhibitors?

Circulation. 2022 Dec 20;146(25):1899-1902. doi: 10.1161/CIRCULATIONAHA.122.061132. Epub 2022 Dec 19.

Authors

Jeffrey I Weitz^{1

2

3}, John W Eikelboom^{1

2

4}

Affiliations

¹ Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.I.W., J.W.E.).
² Departments of Medicine (J.I.W., J.W.E.), McMaster University, Hamilton, Ontario, Canada.
³ Biochemistry and Biomedical Sciences (J.I.W.), McMaster University, Hamilton, Ontario, Canada.
⁴ Population Health Research Institute, Hamilton, Ontario, Canada (J.W.E.).

PMID: 36534732
DOI: 10.1161/CIRCULATIONAHA.122.061132

No abstract available

Keywords: anticoagulants; atrial fibrillation; factor XI.

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Factor XI
Factor Xa Inhibitors / therapeutic use
Humans
Stroke* / drug therapy

Substances

Factor XI
Anticoagulants
Factor Xa Inhibitors